South Carolina

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

News

Diagnostics firm Lab21 licenses molecular diagnostics technology

Molecular diagnostics technology developed by Cooperative Diagnostics has caught the eye of United Kingdom firm Lab21 Limited, which has signed an exclusive worldwide license to develop the technology into new personalized medicine tests. No financial terms between Lab21 and Greenwood, South Carolina-based Cooperative Diagnostics were disclosed. Cooperative Diagnostics has developed custom nucleic acid tests that […]

Pharma

Synthetic biology firm Intrexon starts $50M fundraising round

Biotechnology company Intrexon has launched a new fundraising round aimed at bringing in $50 million in new investment. The DNA technologies company has raised $17 million in equity financing in the effort so far, according to securities filings. Last year, Intrexon closed a $100 million series E round of financing to expand its genetics technology. […]

News

Cancer pathways firm PathForward appoints first CEO

Cancer care pathways company PathForward Oncology has named health insurance executive Brian Litten as the new company’s first CEO. Bluffton, South Carolina-based PathForward is a new joint venture formed by benefits management company CareCore National and D3 Oncology Solutions, an affiliate of UPMC Cancer Centers in Pittsburgh. A cancer care pathway is essentially a guideline […]

Pharma

Human antibodies biotech firm Immunologix acquired by Intrexon

South Carolina biotechnology company Immunologix has been acquired by Virginia DNA technologies company Intrexon, which earlier this year raised $100 million in a series E round of fundraising. Charleston, South Carolina-based Immunologix has developed technology that transforms naive B lymphocytes into antibodies that can target a wide range of antigens including cancer, viruses, bacteria and […]

Devices & Diagnostics

Blood glucose technologies company Glytec raises $8.2M

Glytec, a company whose technology helps diabetics monitor and manage their blood glucose levels, has raised $8.27 million in equity financing that the company will use to support growth in the United States and abroad, as well as for continued research and development. According to securities filings, the glycemic  management systems company’s parent targeted the […]

Pharma

Human antibody company Immunologix starts raising $1.1 million

South Carolina biotech company Immunologix has raised nearly $250,000 in a financing round targeting $1.1 million, according to securities filings. Charleston, South Carolina-based Immunologix has developed technology that produces human antibodies that can target bacteria, viruses and even cancer. The company is now raising money again after bringing in just over $1 million in equity […]

Health IT

Electronic medical records system may include video

Electronic medical records may include video, if South Carolina startup CareCam Innovations has its way. The company wants to make video the standard way of recording and storing information for electronic medical records. CareCam is still in R&D, but has just landed a $200,000 investment that will help develop its technology.